139 related articles for article (PubMed ID: 3856545)
1. The effects of prostaglandin F2 alpha in the human eye.
Giuffrè G
Graefes Arch Clin Exp Ophthalmol; 1985; 222(3):139-41. PubMed ID: 3856545
[TBL] [Abstract][Full Text] [Related]
2. The effect of prostaglandin F2 alpha on intraocular pressure in normotensive human subjects.
Lee PY; Shao H; Xu LA; Qu CK
Invest Ophthalmol Vis Sci; 1988 Oct; 29(10):1474-7. PubMed ID: 3170119
[TBL] [Abstract][Full Text] [Related]
3. Effects of topically applied prostaglandin F2 alpha on normotensive human eyes.
Erkiliç K; Ekinciler OF; Mirza GE; Doğan H; Cağil N
Ophthalmic Res; 1996; 28(6):351-5. PubMed ID: 9032793
[TBL] [Abstract][Full Text] [Related]
4. Maintained reduction of intraocular pressure by prostaglandin F2 alpha-1-isopropyl ester applied in multiple doses in ocular hypertensive and glaucoma patients.
Camras CB; Siebold EC; Lustgarten JS; Serle JB; Frisch SC; Podos SM; Bito LZ
Ophthalmology; 1989 Sep; 96(9):1329-36; discussion 1336-7. PubMed ID: 2780003
[TBL] [Abstract][Full Text] [Related]
5. Intraocular pressure reduction with PhXA34, a new prostaglandin analogue, in patients with ocular hypertension.
Camras CB; Schumer RA; Marsk A; Lustgarten JS; Serle JB; Stjernschantz J; Bito LZ; Podos SM
Arch Ophthalmol; 1992 Dec; 110(12):1733-8. PubMed ID: 1463414
[TBL] [Abstract][Full Text] [Related]
6. Effects of topically applied prostaglandin F2 alpha tromethamine salt on glaucomatous human eyes.
Erkiliç K; Ekinciler OF; Mirza GE; Doğan H; Cagil N
Int J Clin Pharmacol Res; 1996; 16(2-3):51-5. PubMed ID: 9063756
[TBL] [Abstract][Full Text] [Related]
7. Effects of prostaglandin D2 and its analogue, BW245C, on intraocular pressure in humans.
Nakajima M; Goh Y; Azuma I; Hayaishi O
Graefes Arch Clin Exp Ophthalmol; 1991; 229(5):411-3. PubMed ID: 1937072
[TBL] [Abstract][Full Text] [Related]
8. In-vivo activity and enzymatic hydrolysis of novel prostaglandin F2 alpha prodrugs in ocular tissues.
Woodward DF; Chan MF; Cheng-Bennett A; Wheeler LA; Chen G; Burke JA; Kharlamb A; Lai RK; Shan T
Exp Eye Res; 1996 Oct; 63(4):411-23. PubMed ID: 8944548
[TBL] [Abstract][Full Text] [Related]
9. Multiple dosing of prostaglandin F2 alpha or epinephrine on cynomolgus monkey eyes. II. Slit-lamp biomicroscopy, aqueous humor analysis, and fluorescein angiography.
Camras CB; Bhuyan KC; Podos SM; Bhuyan DK; Master RW
Invest Ophthalmol Vis Sci; 1987 Jun; 28(6):921-6. PubMed ID: 3473055
[TBL] [Abstract][Full Text] [Related]
10. Ocular hypotensive effect of PhXA41 in patients with ocular hypertension or primary open-angle glaucoma.
Hotehama Y; Mishima HK; Kitazawa Y; Masuda K
Jpn J Ophthalmol; 1993; 37(3):270-4. PubMed ID: 8295364
[TBL] [Abstract][Full Text] [Related]
11. The effects on aqueous dynamics of PhXA41, a new prostaglandin F2 alpha analogue, after topical application in normal and ocular hypertensive human eyes.
Ziai N; Dolan JW; Kacere RD; Brubaker RF
Arch Ophthalmol; 1993 Oct; 111(10):1351-8. PubMed ID: 8216015
[TBL] [Abstract][Full Text] [Related]
12. Prostaglandin F2 alpha-isopropylester eye drops: effects in normal human eyes.
Villumsen J; Alm A
Br J Ophthalmol; 1989 Jun; 73(6):419-26. PubMed ID: 2751973
[TBL] [Abstract][Full Text] [Related]
13. Studies on the ocular pharmacology of prostaglandin D2.
Woodward DF; Hawley SB; Williams LS; Ralston TR; Protzman CE; Spada CS; Nieves AL
Invest Ophthalmol Vis Sci; 1990 Jan; 31(1):138-46. PubMed ID: 2298534
[TBL] [Abstract][Full Text] [Related]
14. Reduction of intraocular pressure in normal and glaucomatous primate (Aotus trivirgatus) eyes by topically applied prostaglandin F2 alpha.
Camras CB; Bito LZ
Curr Eye Res; 1981; 1(4):205-9. PubMed ID: 6949676
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the ocular hypotensive efficacy of eicosanoids and related compounds.
Bito LZ
Exp Eye Res; 1984 Feb; 38(2):181-94. PubMed ID: 6370708
[TBL] [Abstract][Full Text] [Related]
16. Conjunctival hyperemia and the use of topical prostaglandins in glaucoma and ocular hypertension.
Feldman RM
J Ocul Pharmacol Ther; 2003 Feb; 19(1):23-35. PubMed ID: 12648301
[TBL] [Abstract][Full Text] [Related]
17. Multiple dosing of prostaglandin F2 alpha or epinephrine on cynomolgus monkey eyes. III. Histopathology.
Camras CB; Friedman AH; Rodrigues MM; Tripathi BJ; Tripathi RC; Podos SM
Invest Ophthalmol Vis Sci; 1988 Sep; 29(9):1428-36. PubMed ID: 3166452
[TBL] [Abstract][Full Text] [Related]
18. Intraocular pressure-reducing effect of PhXA41 in patients with increased eye pressure. A one-month study.
Alm A; Villumsen J; Törnquist P; Mandahl A; Airaksinen J; Tuulonen A; Marsk A; Resul B; Stjernschantz J
Ophthalmology; 1993 Sep; 100(9):1312-6; discussion 1316-7. PubMed ID: 8371917
[TBL] [Abstract][Full Text] [Related]
19. Ocular effects of two different prostaglandin F2 alpha esters. A doublemasked cross-over study on normotensive eyes.
Villumsen J; Alm A
Acta Ophthalmol (Copenh); 1990 Jun; 68(3):341-3. PubMed ID: 2392914
[TBL] [Abstract][Full Text] [Related]
20. Long-term maintenance of reduced intraocular pressure by daily or twice daily topical application of prostaglandins to cat or rhesus monkey eyes.
Bito LZ; Draga A; Blanco J; Camras CB
Invest Ophthalmol Vis Sci; 1983 Mar; 24(3):312-9. PubMed ID: 6572617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
